Who's building new pharma factories and who might be spared from 100% tariffs

Who's building new pharma factories and who might be spared from 100% tariffs

Views from pharma execs J&J’s Duato: tariffs “can create disruptions in the supply chain, leading to shortages” and tax policy is a better tool to grow U.S. capacity. Healthcare Brew AstraZeneca’s chair: “medicines should be exempted from any kind of tariffs” because they harm patients and restrict health equity. Bloomberg Policy backdrop: Commerce launched a… The post Who’s building in pharma, and who would be spared from 100% tariffs, if enact…